Intradermal immunization with botulinum neurotoxin serotype E DNA vaccine induces humoral and cellular immunity and protects against lethal toxin challenge

References

• Sobel J. Botulism. Clinic Infect Dis. 2005;41:1167–1173. doi:10.1086/444507.
   PubMed Web of Science ®Google Scholar
• CDC. Botulism. Altlanta (GA): Centers of disease control and prevention 2017; 2017.
   Google Scholar
• Wheeler A, Smith HS. Botulinum toxins: mechanism of action, antinociception and clinical application. Toxicology. 2013;306:124–146. doi:10.1016/j.tox.2013.02.006.
   PubMed Web of Science ®Google Scholar
• Middlebrook JL. Production of vaccines against leading biowarfare toxins can utilize DNA scientific technology. Adv Drug Delivery Rev. 2005;57:1415–1423. doi:10.1016/j.addr.2005.01.016.
   PubMed Web of Science ®Google Scholar
• Aron SS, Schechter R, Inglesby TV, Henderson DA, Barlett JG, Ascher MS, Eitzen E, Fine AD, Hauer J, Layton M, et al. Botulinum toxin as biological weapon: medical and public health management. JAMA. 2001;285:1059–1070.
   PubMed Web of Science ®Google Scholar
• Barash JR, Arnon SS. A novel strain of Clostridium botulinum that produces type B and type H botulinum toxins. J Infect Dis. 2014;209:183–191. doi:10.1093/infdis/jit449.
   PubMed Web of Science ®Google Scholar
• Simpson LL. Identification of the major step in botulinum toxin action. Annu Rev Pharmacol Toxicol. 2004;44:167–193. doi:10.1146/annurev.pharmtox.44.101802.121554.
   PubMed Web of Science ®Google Scholar
• Dickerson TJ, Janda KD. The use of small molecules to investigate molecular mechanism and therapeutic targets for treatment of botulinum neurotoxin A intoxication. ACS Chem Bio. 2006;6:359–369. doi:10.1021/cb600179d.
   Web of Science ®Google Scholar
• Montecucco C, Rossetto O, Schiavo G. Presynaptic receptor arrays for clostridial neurotoxins. Trends Microbiol. 2004;12:442–446. doi:10.1016/j.tim.2004.08.002.
   PubMed Web of Science ®Google Scholar
• Byrne MP, Smith LA. Development of vaccines for prevention of botulism. Biochemie. 2000;82:955–966. doi:10.1016/S0300-9084(00)01173-1.
   PubMed Web of Science ®Google Scholar
• Sundeen G, Barbieri JT. Vaccines against botulism. Toxins. 2017;9:268. doi:10.3390/toxins9090268.
   PubMed Web of Science ®Google Scholar
• Garmory HS, Perkins SD, Phillpotts RJ, Titball RW. DNA vaccines for biodefence. Adv Drug Delivery Rev. 2005;57:1343–1361. doi:10.1016/j.addr.2005.01.013.
   PubMed Web of Science ®Google Scholar
• Tregoning JS, Kinnear E. Using plasmids as DNA vaccines for infectious diseases. Microbiol Spectr. 2014;2:PLAS-0028-2014.
   PubMedGoogle Scholar
• Smith LA. Botulism and vaccines for its prevention. Vaccine. 2009;27:D33–39. doi:10.1016/j.vaccine.2009.08.059.
   PubMed Web of Science ®Google Scholar
• Bennett AM, Perkins SD, Holley PJ. DNA vaccination protects against botulism neurotoxi in type F. Vaccine. 2003;21:3110–3117.
   PubMed Web of Science ®Google Scholar
• Trollet C, Pereira Y, Burgain A, Litzler E, Mezrahi M, Seguin J, Manich M, Popoff MR, Scherman D, Bigey P. Generation of high-titer neutralizing antibodies against botulinum toxins A, B, and E by electrotransfer. Infect Immun. 2009;77:2221–2229. doi:10.1128/IAI.01269-08.
   PubMed Web of Science ®Google Scholar
• Smith TJ, Roxas-Duncan VI, Smith LA. Botulinum neurotoxins as biothreat agents. J Bioterr Biodef. 2014;S2:003.
   Google Scholar
• Clayton J, Middlebrook JL. Vaccination of mice with DNA encoding a large fragment of botulinum neurotoxin serotype A. Vaccine. 2000;18:1855–1862.
   PubMed Web of Science ®Google Scholar
• Zeng M, Xu Q, Elias M, Pichichero ME, Simpson LL, Smith LA. Protective immunity against botulism provided by a single dose vaccination with an adenovirus-vectored vaccine. Vaccine. 2007;25:7540–7548. doi:10.1016/j.vaccine.2007.08.035.
   PubMed Web of Science ®Google Scholar
• Kupper TS, Fuhlbrigge RC. Immune surveillance in the skin: mechanism and clinical consequences. Nat Rev Immunol. 2004;4:211–222. doi:10.1038/nri1310.
   PubMed Web of Science ®Google Scholar
• Dux MP, Barent R, Sinha J, Gouthro M, Swanson T, Barthuli A, Iana M, Ross JT, Smith LA, Smith TJ, et al. Purification and scale up of a recombinant heavy chain fragment C of botulinum neurotoxin serotype E in Pichia pastoris GS115. Protein Expr Puri. 2006;45:359–367. doi:10.1016/j.pep.2005.08.015.
   PubMed Web of Science ®Google Scholar
• Zichel R, Mimran A, Keren A, Barnea A, Steinberger-Levy I, Marcus D, Turgeman A, Reuveny S. Efficiency of a potential trivalent vaccine based on HC fragments of botulinum toxins A, B, and E produced in a cell-free expression system. Clin Vaccine Immunol. 2010;17:784–792. doi:10.1128/CVI.00496-09.
   PubMed Web of Science ®Google Scholar
• Hess J, Schaible U, Raupach B, Kaufmann SH. Exploiting the immune system: toward new vaccines against intracellular bacteria. Adv Immunol. 2000;75:1–88.
   PubMed Web of Science ®Google Scholar
• Visciano ML, Tagliamonte M, Tornesello ML, Buonaguro FM, Buonaguro L. Effects of adjuvants on IgG subclasses elicited by virus-like particles. J Transl Med. 2012;10:4. doi:10.1186/1479-5876-10-233.
   PubMed Web of Science ®Google Scholar
• Jathoul AP, Holley JL, Garmory HS. Efficacy of DNA vaccines expressing the type F botulinum toxin Hc fragment using different promoters. Vaccine. 2004;22:3942–3946. doi:10.1016/j.vaccine.2004.04.006.
   PubMed Web of Science ®Google Scholar
• Crotty S. A brief history of T cell help to B cell. Nat Rev Immunol. 2015;15:185–189. doi:10.1038/nri3803.
   PubMed Web of Science ®Google Scholar
• Scott VL, Villarreal DO, Hutnick NA, Walters JN, Ragwan E, Bdeir K, Yan J, Sardesai NY, Finnefrock AC, Casimiro DR, et al. DNA vaccines targeting heavy chain C-terminal fragments of Clostridium botulinum neurotoxin serotypes A, B, and E induce potent humoral and cellular immunity and provide protection from lethal toxin challenge. Hum Vaccin Immunother. 2015;11:1961–1971. doi:10.1080/21645515.2015.1066051.
   PubMed Web of Science ®Google Scholar
• Kim NY, Chang DS, Kim Y, Kim CH, Hur GH, Yang JM, Shin S. Enhanced immune response to DNA vaccine encoding Bacillus anthracis PA-D4 protects mice against anthrax spore challenge. PLoS One. 2015;10:e0139671. doi:10.1371/journal.pone.0139671.
   PubMed Web of Science ®Google Scholar